Photo: MintHyderabad: Glenmark Pharmaceuticals Ltd on Wednesday launched Digihaler, India’s first digital dose inhaler for asthma and chronic obstructive pulmonary disease (COPD) patients. Glenmark planning to launch more drugs to support Digihaler in coming monthsGlenmark said it has already launched two combination drugs that will go in with the inhaler. Glenmark said it has already launched two combination drugs that will go in with the inhaler. “This inhaler provides accurate digital dose counter along with low dose warning indicator to enable asthma and chronic patients to track adherence to their therapy,” Glenmark said. The product costs Rs.300-450, depending on the strength and the combination of drugs in the inhaler.

Source: Mint May 25, 2016 10:37 UTC